These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 30556836)

  • 1. Challenges of Non-Intention-to-Treat Analyses.
    DeMets DL; Cook T
    JAMA; 2019 Jan; 321(2):145-146. PubMed ID: 30556836
    [No Abstract]   [Full Text] [Related]  

  • 2. Statistics Commentary Series: Commentary #10-Dealing With Drop-Outs.
    Streiner DL
    J Clin Psychopharmacol; 2015 Oct; 35(5):496-8. PubMed ID: 25803367
    [No Abstract]   [Full Text] [Related]  

  • 3. Can We Trust Knee Meniscus Studies? One-Way Crossover Confounds Intent-to-Treat Statistical Methods.
    Lubowitz JH; D'Agostino RB; Provencher MT; Rossi MJ; Brand JC
    Arthroscopy; 2016 Nov; 32(11):2187-2190. PubMed ID: 27816090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review finds variable use of the intention-to-treat principle in musculoskeletal randomized controlled trials with missing data.
    Joseph R; Sim J; Ogollah R; Lewis M
    J Clin Epidemiol; 2015 Jan; 68(1):15-24. PubMed ID: 25304501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Primary Outcome Is Positive - Is That Good Enough?
    Pocock SJ; Stone GW
    N Engl J Med; 2016 Sep; 375(10):971-9. PubMed ID: 27602669
    [No Abstract]   [Full Text] [Related]  

  • 6. The implications of non-compliance: Randomised controlled trials: the intention-to-treat principle.
    Platt AC; Turner EL
    BJOG; 2019 Oct; 126(11):1337. PubMed ID: 31222882
    [No Abstract]   [Full Text] [Related]  

  • 7. Adjusting for Nonadherence or Stopping Treatments in Randomized Clinical Trials.
    Adler AI; Latimer NR
    JAMA; 2021 May; 325(20):2110-2111. PubMed ID: 34032845
    [No Abstract]   [Full Text] [Related]  

  • 8. Intention-to-treat in randomized controlled trials: recommendations for a total trial strategy.
    Polit DF; Gillespie BM
    Res Nurs Health; 2010 Aug; 33(4):355-68. PubMed ID: 20645423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precise definitions of some terminology for longitudinal clinical trials: subjects, patient populations, analysis sets, intention to treat, and related terms.
    Helms RW
    Pharm Stat; 2016 Nov; 15(6):471-485. PubMed ID: 27620652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addressing missing participant outcome data in dental clinical trials.
    Spineli LM; Fleming PS; Pandis N
    J Dent; 2015 Jun; 43(6):605-18. PubMed ID: 25837533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comment to the reply letter: Letter to the Editor: Preference option randomized design (PORD) for comparative effectiveness research: Statistical power for testing comparative effect, preference effect, selection effect, intent-to-treat effect, and overall effect (SMMR, Vol. 28, Issue 2, 2019).
    Walter SD; Macaskill P; Turner R; Guyatt G; Cook R; Prasad K
    Stat Methods Med Res; 2019 May; 28(5):1603. PubMed ID: 29633654
    [No Abstract]   [Full Text] [Related]  

  • 12. Demystifying intention-to-treat analyses.
    Tufanaru C
    JBI Database System Rev Implement Rep; 2017 Apr; 15(4):853-854. PubMed ID: 28398970
    [No Abstract]   [Full Text] [Related]  

  • 13. Intention to treat analysis: how frequently is it used in ENT randomised controlled trials?
    Achar P; Mitra I; Duvvi S; Kumar BN
    Clin Otolaryngol; 2010 Feb; 35(1):65-7. PubMed ID: 20447170
    [No Abstract]   [Full Text] [Related]  

  • 14. Deviation from intention to treat analysis in randomised trials and treatment effect estimates: meta-epidemiological study.
    Abraha I; Cherubini A; Cozzolino F; De Florio R; Luchetta ML; Rimland JM; Folletti I; Marchesi M; Germani A; Orso M; Eusebi P; Montedori A
    BMJ; 2015 May; 350():h2445. PubMed ID: 26016488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Approaches to data analyses of clinical trials.
    Furberg CD; Friedman LM
    Prog Cardiovasc Dis; 2012; 54(4):330-4. PubMed ID: 22225999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial: Estimands in clinical trials - a challenge to intention to treat?
    Day S
    Stat Med; 2017 Jan; 36(1):3-4. PubMed ID: 27917553
    [No Abstract]   [Full Text] [Related]  

  • 17. A systematic review found that deviations from intention-to-treat are common in randomized trials and systematic reviews.
    Abraha I; Cozzolino F; Orso M; Marchesi M; Germani A; Lombardo G; Eusebi P; De Florio R; Luchetta ML; Iorio A; Montedori A
    J Clin Epidemiol; 2017 Apr; 84():37-46. PubMed ID: 28088592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intention-to-treat analysis.
    Elkins MR; Moseley AM
    J Physiother; 2015 Jul; 61(3):165-7. PubMed ID: 26096012
    [No Abstract]   [Full Text] [Related]  

  • 19. Assessing the treatment effect in a randomized controlled trial with extensive non-adherence: the EVOLVE trial.
    Kubo Y; Sterling LR; Parfrey PS; Gill K; Mahaffey KW; Gioni I; Trotman ML; Dehmel B; Chertow GM
    Pharm Stat; 2015; 14(3):242-51. PubMed ID: 25851955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Including or excluding data: intention-to-treat and completer analyses].
    Böhnke JR; Lutz W
    Psychother Psychosom Med Psychol; 2012 Nov; 62(11):429. PubMed ID: 23143830
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.